  Kingstown Capital Partners is Buying Novelion Therapeutics Inc. (NASDAQ:NVLN) Shares - Small Cap Exclusive                 Kingstown Capital Partners is Buying Novelion Therapeutics Inc. (NASDAQ:NVLN) SharesHomeBiotech, Healthcare, NewsKingstown Capital Partners is Buying Novelion Therapeutics Inc. (NASDAQ:NVLN) Shares Kingstown Capital Partners is Buying Novelion Therapeutics Inc. (NASDAQ:NVLN) Shares April 5, 2017 |  0 |  Richard Schwarz | Biotech |  In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Novelion Therapeutics Inc. (NASDAQ:NVLN) reported that Kingstown Capital Partners, Llc. has picked up 358,460 of common stock as of 2017-04-05.The acquisition brings the aggregate amount owned by Kingstown Capital Partners, Llc. to a total of 358,460 representing a 1.9% stake in the company.For those not familiar with the company, Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company’s portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.A glance at Novelion Therapeutics Inc. (NASDAQ:NVLN)’s key stats reveals a current market capitalization of 195.73 Million based on 18.53 Million shares outstanding and a price at last close of $10.65 per share.Looking at insider activity, there are a few transactions worth noting.Specifically, on 2016-09-15, Stonepine picked up 14,928 at a purchase price of $1.55. This brings their total holding to 5,778,496 as of the date of the filing.On the sell side, the most recent transaction saw Axial unload 8,865,036 shares at a sale price of $3.47. This brings their total holding to 0.It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Novelion Therapeutics Inc. (NASDAQ:NVLN) as things move forward to see if its progress aligns with these transactions.Subscribe below and we’ll keep you on top of what’s happening before it moves markets.    Tags Biopharmaceuticals Health care NASDAQ:NVLN SHARE :  Richard Schwarz  Richard Schwarz is a veteran analyst in the small cap space, with a particular focus on the development stage biotech sector. He is a native of Canada, and attended NYU before working for a host of big name pharma outfits.Related Post:   Here is Who Picked Incyte Corp (NASDAQ:INCY) Shares     April 28, 2017    0    Agios Pharmaceuticals Inc. (NASDAQ:AGIO) is Attracting Smart Money     April 24, 2017    0    Rtw Investments is Buying Ptc Therapeutics Inc. (NASDAQ:PTCT) Shares     April 21, 2017    0    Here’s Who Just Picked Up Dynatronics Corp (NASDAQ:DYNT) Shares     April 19, 2017    0 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *CommentName * Email * Website   Top Brokers  Review Trade Now  ReviewTrade Now  ReviewTrade NowPromotionCopyright 2016 - All Rights ReservedTOPEnter your name and email and get the weekly newsletter... it's FREE!Introduce yourself and your programYour information will *never* be shared or sold to a 3rd party.        Michael Blitzer - Kingstown Capital Management - 2017 Stock Picks and Performance - Insider Monkey                          Companies 0 See All     Hedge Funds 0 See All    Insiders 0 See All    Institutional Investors 0 See All   Click here to see all  results for  Sorry, no results has been found matching your query.                   Adblocker Detected    Dear Valued Visitor, We have noticed that you are using an ad blocker software.
    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. To view this article, you can disable your ad blocker and refresh this page or simply login. We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.       Home > Hedge Funds > Kingstown Capital Management
				> Profile    Hedge Fund - Kingstown Capital Management  Get Email Alerts     Profile Holdings Latest 13D & 13G Filings News, Interviews, and Investor Letters     Get Email Alerts  Profile Holdings Latest 13D & 13G Filing News     Michael Blitzer Bio, Returns, Net Worth     Founded by Michael Blitzer, Kingstown Capital Management is a "value-oriented investment partnership that focuses on special situation securities across the capital structure," according to the fund itself. Kingstown Capital manages a mid-sized 13F equity portfolio of a little over $500 million, with total AUM of $977 million.                    Fund Profile  Filing Period:  2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31          Fund Name: Kingstown Capital Management   Manager Michael Blitzer   Portfolio Value $963,535,000   Change This QTR +0.94%                 Top Holdings  Login to See All Holdings | Sign up      Filing Period:  2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31     Last updated on May 12, 2017, 8:26 pm based on SEC 13F filings Last update: May 12, 2017, 8:26 pm              No.  Security  Ticker  Shares  Value (x$1000)  Activity  % Port      1. Adient Plc  2,500,000 $181,675  18.85%   2. Hewlett Packard Enterprise Co HPE 4,000,000 $94,800 -12% 9.83%   3. Cit Group Inc CIT 1,750,000 $75,128 -6% 7.79%   4. General Motors Co GM 2,100,000 $74,256  7.7%   5. Forest City Rlty Tr Inc  3,000,000 $65,340 +20% 6.78%        Login to See All Holdings | Sign up, It's FREE       News, Interviews and Investor Letters See All        13D Filing: Kingstown Capital Partners, Llc and Novelion Therapeutics Inc. (NASDAQ:NVLN) ...... (read more) April 8th, 2017 -  Hedge Funds - Comments         140 Biggest and Most Famous Activist Hedge Funds After all, activist hedge funds get most of their earnings from investing in companies and pushing them to provide more shareholder value. These funds and their managers can start off with a statement...... (read more) February 2nd, 2017 -  Hedge Funds News - Comments         Ocwen Financial Corp (OCN): Kingstown Capital Management Lowers Stake A newly-amended 13D filing with the Securities and Exchange Commission revealed that Michael Blitzer's Kingstown Capital Management has lowered its stake in Ocwen Financial Corp (NYSE:OCN) to 9.5 million...... (read more) September 5th, 2016 -  Hedge Funds News - Comments         Home Loan Servicing Solutions Ltd (HLSS), Ocwen Financial Corp (OCN),  News Corp (NWS): Kingstown Capital’s Latest Moves and Top Picks Michael Blitzer’s Kingstown Capital Management disclosed a large new activist position last week in Home Loan Servicing Solutions Ltd (NASDAQ:HLSS), with 3.6 million shares representing 5.1% of that...... (read more) March 1st, 2015 -  Hedge Funds News - Comments         Vodafone Group Plc (ADR) (VOD), General Motors Company (GM) Among Kingstown Capital’s ‘Killer’ Stock Picks With a medium-sized equity portfolio and assets under management worth $977 million, Kingstown Capital Management is a hedge fund founded and managed by Michael Blitzer. In this piece we will discover...... (read more) August 4th, 2013 -  Hedge Funds - Comments       Click here to See All News           Hedge Fund Resource Center    How to Beat the Market by 20 Percentage Points Why Track Hedge Funds? Download a Free Edition! Why You Should DUMP Your Hedge Funds 6 Things You Didn't Know About Hedge Funds        Billionaire Hedge Funds          Warren Buffett Berkshire Hathaway $147,985,198,000          David Einhorn Greenlight Capital $5,818,885,000          George Soros Soros Fund Management $4,321,285,000          T Boone Pickens BP Capital $318,631,000          Jim Simons Renaissance Technologies $63,208,016,000          Leon Cooperman Omega Advisors $2,269,539,000          Carl Icahn Icahn Capital LP $22,373,522,000          Steve Cohen Point72 Asset Management $14,303,015,000          John Paulson Paulson & Co $7,934,312,000          David Tepper Appaloosa Management LP $5,640,040,000          Paul Tudor Jones Tudor Investment Corp $3,883,628,000          Stanley Druckenmiller Duquesne Capital $1,026,024,000          Julian Robertson Tiger Management $551,620,000          Ray Dalio Bridgewater Associates $10,528,018,000          Ken Fisher Fisher Asset Management $57,428,877,000          Bill Ackman Pershing Square $5,913,210,000          Edward Lampert ESL Investments $652,929,000          Dan Loeb Third Point $10,188,461,000          Ken Griffin Citadel Investment Group $99,007,951,000          Israel Englander Millennium Management $47,754,732,000          Michael Price MFP Investors $824,193,000              Home Hedge Funds Markets Blog Authors About Us Contact Us Privacy Policy Terms of Use Site Map  All text and design is copyright ©2016 Koala Guide LLC. All rights reserved.             

Kingstown Capital Management





















Contact
Office
Clients






					Kingstown Capital Management, LP is a 
					value-oriented investment partnership 
					that focuses on special situation securities 
					across the capital structure.
				






Patrick Levens 
					Chief Financial Officer
					






Kingstown Capital Management, LP 
P 212 319 1309 | F 646 895 7633 
info@kingstowncapital.com
					100 Park Avenue, Suite 2100 
					New York, NY 10017
					







Login











© 2010 Kingstown Capital Management, LP










Kingstown Capital Management





















Contact
Office
Clients






					Kingstown Capital Management, LP is a 
					value-oriented investment partnership 
					that focuses on special situation securities 
					across the capital structure.
				






Patrick Levens 
					Chief Financial Officer
					






Kingstown Capital Management, LP 
P 212 319 1309 | F 646 895 7633 
info@kingstowncapital.com
					100 Park Avenue, Suite 2100 
					New York, NY 10017
					







Login











© 2010 Kingstown Capital Management, LP










Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Kingstown Capital Management, LP: Private Company Information - Bloomberg









































  





















































































July 29, 2017 4:56 AM ET
Capital Markets

Company Overview of Kingstown Capital Management, LP



Snapshot People




Company Overview
Kingstown Capital Management, LP is an employee owned hedge fund sponsor. The firm primarily provides its services to investment companies and pooled investment vehicles. It invests in the hedging markets. The firm seeks to invest in special situations across the capital structure. Kingstown Capital Management, LP was founded in 2006 and is based in New York City.


100 Park AvenueSuite 2100New York, NY 10017United StatesFounded in 2006



Phone: 212-319-1309

Fax: 646-895-7633

www.kingstowncapital.com







Key Executives for Kingstown Capital Management, LP




Mr. Michael Aaron Blitzer


      	Co-Founder and Managing Partner
      








Mr. Guy Scott Shanon CFA


      	Co-Chief Investment Officer and Managing Partner
      


Age: 49
        







Mr. Patrick Levens


      	Chief Financial Officer
      





Compensation as of Fiscal Year 2017. 



Similar Private Companies By Industry



Company Name
Region



 @Visory LLC United States 1 Road Partners LLC United States 11T Partners, LLC United States 123Jump.com, Inc. United States 1509225 Ontario, Inc. United States




Recent Private Companies Transactions



TypeDate
Target



No transactions available in the past 12 months.




Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Kingstown Capital Management, LP, please visit www.kingstowncapital.com.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close


























Forbes WelcomeCLOSE   More Options   Quote of the Day  Nothing is invented, for it’s written in nature first. Antoni Gaudí, Architect            13D Filing: Kingstown Capital Partners, Llc and Novelion Therapeutics Inc. (NASDAQ:NVLN) - Insider Monkey                                     
        Companies 0 See All     Hedge Funds 0 See All    Insiders 0 See All    Institutional Investors 0 See All   Click here to see all  results for  Sorry, no results has been found matching your query.                   Adblocker Detected    Dear Valued Visitor, We have noticed that you are using an ad blocker software.
    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. To view this article, you can disable your ad blocker and refresh this page or simply login. We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.    
   Hedge Funds  13D Filing: Kingstown Capital Partners, Llc and Novelion Therapeutics Inc. (NASDAQ:NVLN)    Published on April 8, 2017 at 11:25 am by  
                                Insider Monkey Staff
                                  in Hedge Funds         Page 1 of 13Next &gt&gt          You can access the original SEC filing by clicking here. Ownership Summary Table   Name   Sole Voting Power   Shared Voting Power   Sole Dispositive Power   Shared Dispositive Power   Aggregate Amount Owned Power   Percent of Class    KINGSTOWN PARTNERS MASTER LTD         358,460   358,460   1.9%  KINGSTOWN PARTNERS II         103,291   103,291   LESS THAN 1%  KTOWN         100,228   100,228   LESS THAN 1%  KINGSTOWN CAPITAL PARTNERS         203,519   203,519   1.1%  KINGSTOWN CAPITAL MANAGEMENT         561,979   561,979   3.0%  KINGSTOWN MANAGEMENT GP         561,979   561,979   3.0%  MICHAEL BLITZER         561,979   561,979   3.0%  GUY SHANON         561,979   561,979   3.0%   Page 1 of 13 – SEC Filing  UNITED STATES SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED
IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 5)1 Novelion Therapeutics Inc. (Name
of Issuer) Common Shares, no par value (Title of Class of Securities) 67001K 20 2 (CUSIP Number) STEVE
WOLOSKY, ESQ. OLSHAN
FROME WOLOSKY LLP 1325
Avenue of the Americas New
York, New York 10019 (212)
451-2300 (Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications) April 3, 2017 (Date of Event Which Requires
Filing of This Statement) If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box ¨. Note:  Schedules
filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.    1
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page. The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).           Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)Follow Novelion Therapeutics Inc. (NASDAQ:NVLN)       Trade (NASDAQ:NVLN) Now!        Page 1 of 13Next &gt&gt       Related Insider Monkey Articles13D Filing: Granite Falls Energy, Llc and Heron Lake Bioenergy Llc13D Filing: Maxlinear Inc and Exar Corp (NYSE:EXAR)13D Filing: Mill Road Capital Ii, L.p. and Ecology & Environment Inc (...13D Filing:  Junwei Zheng and Kiwa Bio-Tech Products Group Corp13D Filing: Growth Equity Opportunities Iv, Llc and Aveo Pharmaceuticals Inc...13D Filing: Hudson Executive Capital and Cabot Microelectronics Corp (NASDAQ... hedge fund:149 Kingstown Capital Partners LLC NASDAQ:NVLN Novelion Therapeutics Inc. (NASDAQ:NVLN) SEC 13D Filing                Insider Monkey Small Cap Strategy      Download a free copy of our newsletter and see the details inside!     Hedge Fund Resource Center    How to Beat the Market by 20 Percentage Points Why Track Hedge Funds? Download a Free Edition! Why You Should DUMP Your Hedge Funds 6 Things You Didn't Know About Hedge Funds      Billionaire Hedge Funds          Warren Buffett Berkshire Hathaway $147,985,198,000          David Einhorn Greenlight Capital $5,818,885,000          George Soros Soros Fund Management $4,321,285,000          T Boone Pickens BP Capital $318,631,000          Jim Simons Renaissance Technologies $63,208,016,000          Leon Cooperman Omega Advisors $2,269,539,000          Carl Icahn Icahn Capital LP $22,373,522,000          Steve Cohen Point72 Asset Management $14,303,015,000          John Paulson Paulson & Co $7,934,312,000          David Tepper Appaloosa Management LP $5,640,040,000           About Us Contact Us Terms Of Use Privacy Policy       Next Post

   Home Hedge Funds Markets Blog Authors About Us Contact Us Privacy Policy Terms of Use Site Map  All text and design is copyright ©2016 Koala Guide LLC. All rights reserved.            
















Bing Places for Business
























































































































Bing
 places for business


Sign in using your




Microsoft Account





Work Account





Google Account





Facebook Account

Don't have an account? Create one.






Kingstown Capital Partners Llc in New York, NY 10022 - ChamberofCommerce.com




   =     


        









Sign Up
Sign In
Contact Us


 














Search
 

near
 













Home
» New York
» New York
» Portfolio Management & Investment Services
» Kingstown Capital Partners Llc













Kingstown Capital Partners Llc


0 Reviews

0.0000 stars - based on 0 reviews
                            





535 Madison Ave Fl 30 Fl 30 New York, New York 10022


(212) 319-1309
Website


 



 

Print |
                Save |
                Directions


About
Kingstown Capital Partners Llc is located at the address 535 Madison Ave Fl 30 in New York, New York 10022.  They can be contacted via phone at (212) 319-1309 for pricing, hours and directions.  Kingstown Capital Partners Llc has an annual sales volume of 0 - 500K.  .For more information contact Michael  Blitzer, Portfolio Manager or  go to www.kingstowncapital.comFor maps and directions to Kingstown Capital Partners Llc view the map to the right.  For reviews of Kingstown Capital Partners Llc see below.










Information

CONTACT INFORMATION
Phone: (212) 319-1309
Website: www.kingstowncapital.com
ADDITIONAL INFORMATION:
Employee Size: 1 To 4
Exact Employee Count: 3
Exact Sales Volume: 120000
Location Type: Single Location
Sales Volume: 0 - 500K
CATEGORIES:


Portfolio Management & Investment Services
Royalty Services
Finance
Professional Services
Investments & Securities
Legal Services



People Also Viewed


Deutsche Bank


60 Wall St  New York, New York 10005




First Investors Unit Trust Department


95 Wall St Fl 22 New York, New York 10005




ATEC CONSULTING INC


40 Water St  New York, New York 10004




SELECT EQUITY


33 Whitehall St  New York, New York 10004




Eagle Advisors


3 World Financial Ctr 25 Fl New York, New York 10281




Oberon Asset Management


51 Wooster st Fl 4 Fl 4 New York, New York 10013





Reviews

Add


You must Sign in to post reviews.





by  on 






Click here to be the first to review this business...



0 Reviews
 


Key Contacts




Michael  Blitzer
PORTFOLIO MANAGER
Phone: (212) 319-1309 
 



 























 






Site Map
FAQ
Privacy Policy
Terms of Use
About
Partners
Chamber Partner Program
Chamber Member Benefits




Top Cities:
Atlanta
Bronx
Brooklyn
Chicago
Cleveland
Dallas
Denver
Detroit
Houston
Las Vegas
Los Angeles
Miami
Minneapolis
New York
Philadelphia
Phoenix
Saint Louis
San Antonio
San Diego
San Jose


© 2017 CHAMBEROFCOMMERCE.COM













KINGSTOWN CAPITAL PARTNERS, LLC Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      KINGSTOWN CAPITAL PARTNERS, LLC
                    

•   NEW YORK, NY
                      
How do I update this listing?




                                             Kingstown Capital Partners is based out of New York.    WhaleWisdom has at least 36 13D/G filings in our database for Kingstown Capital Partners.
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from KINGSTOWN CAPITAL PARTNERS, LLC, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




kingstown capital partners, llc


535 MADISON AVENUE

NEW YORK
NY
                                                        
                                                    10022


              Business Phone:
              212-319-1309







Recent SEC Filings




SC 13D/A filed on 04/05/2017
SC 13G/A filed on 02/14/2017
SC 13G/A filed on 02/14/2017
SC 13D/A filed on 11/15/2016
SC 13G filed on 10/11/2016
SC 13D/A filed on 09/02/2016
SC 13G filed on 07/08/2016
SC 13D/A filed on 05/02/2016
4 filed on 04/29/2016
3 filed on 03/17/2016











Current 13D/G Holdings


Stock
Sector
Shares Held
Market Value
Rank
Source
Source Date





HOME LN SERVICING SOLUTIONS (HLSSF)


      FINANCE
    

      3,600,000
    

      66,060,000.00
    

      1
    

      13D
    

      2015-02-23
    



PJT Partners Inc (PJT)


      FINANCE
    

      1,000,000
    

      30,880,000.00
    

      2
    

      13G
    

      2016-12-31
    



Assisted Living Concepts Inc. (New) (ALC)


      HEALTH CARE
    

      1,600,000
    

      15,600,000.00
    

      3
    

      13G
    

      2012-12-31
    



CPEX Pharmaceuticals Inc (CPEX)


      HEALTH CARE
    

      164,372
    

      4,602,416.00
    

      4
    

      13D
    

      2011-03-14
    



Tigrent Inc (TIGE)


      CONSUMER DISCRETIONARY
    

      1,203,450
    

      565,621.50
    

      5
    

      13D
    

      2010-07-01
    











Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free

















